Abstract
Human medicines European public assessment report (EPAR): Deferiprone Lipomed, deferiprone, Iron Overload,beta-Thalassemia, Date of authorisation: 19/09/2018, Revision: 1, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have